Pleural Effusion Caused by Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

被引：2
|
作者：
Rachakonda, Tara [1 ]
Kendall, Brian [2 ]
Spivak, Adam M. [2 ]
Boltax, Jonathan [3 ]
机构：
[1] Univ Utah Hosp & Clin, Dept Med, Salt Lake City, UT USA
[2] Univ Utah Hosp & Clin, Div Infect Dis, Salt Lake City, UT USA
[3] Univ Utah Hosp & Clin, Div Pulm Med, Salt Lake City, UT USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2017年 / 4卷 / 03期
关键词：
bacillus Calmette Guerin; bladder cancer; pleural effusion; INTRAVESICAL THERAPY; BCG INFECTION; COMPLICATIONS;
D O I：
10.1093/ofid/ofx126
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Intravesical bacillus Calmette Guerin (BCG) instillation has been used as immunotherapy for early stage bladder cancer for >40 years. Complications from this therapy are rare but may result in a spectrum of infectious sequelae. Here we describe the case of an elderly man who presented with a pleural effusion and subcutaneous nodule several years after treatment with BCG.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer
    Hugar, Lee A.
    Gilbert, Scott M.
    Sexton, Wade J.
    Kamat, Ashish M.
    Li, Roger
    [J]. CURRENT OPINION IN UROLOGY, 2021, 31 (02) : 160 - 169
  • [22] Poly(I:C) potentiates Bacillus Calmette-Guerin immunotherapy for bladder cancer
    Ayari, Cherifa
    Besancon, Marjorie
    Bergeron, Alain
    LaRue, Helene
    Bussieres, Vanessa
    Fradet, Yves
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (02) : 223 - 234
  • [23] GRANULOMATOUS PROSTATITIS FOLLOWING BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY OF BLADDER-CANCER
    OATES, RD
    STILMANT, MM
    FREEDLUND, MC
    SIROKY, MB
    [J]. JOURNAL OF UROLOGY, 1988, 140 (04): : 751 - 754
  • [24] Recombinant bacillus Calmette-Guerin in urothelial bladder cancer immunotherapy: current strategies
    Wang, Yonghua
    Yang, Meng
    Yu, Qinchao
    Yu, Lun
    Shao, Shixiu
    Wang, Xinsheng
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 85 - 93
  • [25] PRICING AND REIMBURSEMENT ANALYSIS OF BACILLUS CALMETTE-GUERIN (BCG) IMMUNOTHERAPY FOR BLADDER CANCER
    Bekcic, S.
    Mitrovic, I
    Baltezarevic, D.
    Radojevic, V
    Samardzic, J.
    Milenkovic, V
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A654 - A654
  • [26] FASL polymorphism is associated with response to bacillus Calmette-Guerin immunotherapy in bladder cancer
    Lima, Luis
    Ferreira, Jose A.
    Tavares, Ana
    Oliveira, Daniela
    Morais, Antonio
    Videira, Paula A.
    Medeiros, Rui
    Santos, Lucio
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 44.e1 - 44.e7
  • [27] BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY IN OVARIAN-CANCER
    PATTILLO, RA
    KOMAKI, R
    REYNOLDS, M
    ROBLES, J
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 1988, 33 (01) : 41 - 45
  • [28] COMPLICATIONS OF BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY
    LAMM, DL
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1992, 19 (03) : 565 - 572
  • [29] Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
    Khanna, Abhinav
    Yerram, Nitin
    Zhu, Hui
    Kim, Simon
    Abouassaly, Robert
    [J]. UROLOGY, 2019, 124 : 120 - 125
  • [30] BACILLUS CALMETTE-GUERIN IN THE MANAGEMENT OF BLADDER-CANCER
    DROLLER, MJ
    [J]. JOURNAL OF UROLOGY, 1986, 135 (02): : 331 - 333
12345